Atrosimab(Baliopharm)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAtrosimab(Baliopharm)
Drug Alias NameATM-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor receptor inhibitors
TargetsTumor necrosis factor receptor
Therapy Area/IndicationsFibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaliopharm Ag
China Registration ClassN/A

Develop Information

Active CompaniesBaliopharm Ag
Inactive CompaniesN/A
Active IndicationsFibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A